Hughes, Sarah

Publishing since 1970 (Dinosaur)

Has published 178 publications in 41 years

Number of publications published per year by Hughes, Sarah. (Source : PubMed)

Distribution of publications types for Hughes, Sarah. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Kelly S, Hughes S, Nixon S, Paterson-Brown S. Spontaneous pneumomediastinum (Hamman's syndrome).  Surgeon  2010;8;2  
•  Langille M, Bernard A, Rodgers C, Hughes S, Leddin D, van Zanten SV. Systematic review of the quality of patient information on the internet regarding inflammatory bowel disease treatments.  Clin. Gastroenterol. Hepatol.  2010;8;4  
•  Vinh DC, Patel SY, Uzel G, Anderson VL, Freeman AF, Olivier KN, Spalding C, Hughes S, Pittaluga S, Raffeld M, Sorbara LR, Elloumi HZ, Kuhns DB, Turner ML, Cowen EW, Fink D, Long-Priel D, Hsu AP, Ding L, Paulson ML, Whitney AR, Sampaio EP, Frucht DM, DeLeo FR, Holland SM. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.  Blood  2010;115;8  
•  Heerema-McKenney A, Waldron J, Hughes S, Zhan F, Sawyer J, Barlogie B, Shaughnessy JD. Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma.  Am. J. Clin. Pathol.  2010;133;2  
•  Byrd JC, Kipps TJ, Flinn IW, Castro J, Lin TS, Wierda W, Heerema N, Woodworth J, Hughes S, Tangri S, Harris S, Wynne D, Molina A, Leigh B, O'Brien S. Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia.  Blood  2010;115;3  
•  Zweifler J, Hughes S, Lopez RA. Controlling for race/ethnicity: a comparison of California commercial health plans CAHPS scores to NCBD benchmarks.  Int J Equity Health  2010;9  
•  Jiang GC, Hughes S, Stürzenbaum SR, Evje L, Syversen T, Aschner M. Caenorhabditis elegans metallothioneins protect against toxicity induced by depleted uranium.  Toxicol. Sci.  2009;111;2  
•  Hou JM, Greystoke A, Lancashire L, Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A, Ranson M, Lorigan P, Dive C, Blackhall FH. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy.  Am. J. Pathol.  2009;175;2  
•  Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.  J. Viral Hepat.  2009;16;7  
•  Snowdon C, Schierholtz R, Poliszczuk P, Hughes S, van der Merwe G. ETP1/YHL010c is a novel gene needed for the adaptation of Saccharomyces cerevisiae to ethanol.  FEMS Yeast Res.  2009;9;3  

[ See timeline ] [ See all publications ]